The members of OSDD community will be happy to know that the total community members who have registered on Sysborg is now 7074 from 130 countries.The increasing numbers show wide acceptance of OSDD across nations.The active and seriousscientificdiscussions on Sysborgreflects the seriousness of the community in realizing the vision of OSDD.
A new candidate drug against tuberculosis is all set to be tried on drug-resistant TB patients in India with the hope that it would end a 50 year search for a new medicine against the disease that kills 1000 Indians daily. Article by : Mr Kalyan Ray,
posted Jan 18, 2013, 2:10 AM by Anshu Bhardwaj
[
updated Jan 18, 2013, 2:16 AM
]
The final screening of
the 23 shortlisted videos of CSIR-OSDD-VP Short Film Competition-2013 on “Need
of New Drugs for TB” was successfully conducted by a national jury headed by
veteran actor / director Shri Amol Palekar in Kolkata during 06-07 January 2013.
The following videos bagged the prizes. CSIR-OSDD congratulates all the winners
and thank all the participants for their valuable contribution towards raising
the visibility of the urgent need of new drugs for TB.
posted Dec 16, 2012, 8:26 PM by Anshu Bhardwaj
[
updated Dec 16, 2012, 8:26 PM
]
Dr Kalam, who launched the Pharma Vision 2020 programme in 2003, said currently India has one million pharmacists and pharmaceutical scientists. Seventy-five per cent of this human resources is involved in distribution and retailing of drugs in community and hospital sectors. Fifteen to twenty percent of the balance is employed in the areas of manufacturing, quality control, R&D, regulatory, and in academia. The remaining five-10 per cent goes for higher studies or migrates to other countries.
He told the pharmacists that there is ‘the Open Source Drug Discovery’ (OSDD) programme, a CSIR led team India consortium with global partnership, to provide affordable healthcare to the developing world. The factor that affects the developing world is the discouragement of market forces in developing drugs for infectious diseases like tuberculosis, malaria etc. by research based pharmaceutical companies. “In the wake of the discouraging market forces we need to explore new models of drug discovery. This is where OSDD offers a promising new model,” Kalam added.
Chief Mentor OSDD delivered the 25th Foundation Day Lecture of the CSIR-Centre for Cellular & Molecular Biology (CCMB) on Nov 26, 2012. This was celebrated as an international symposium "Biology 2012 and Beyond". The foundation day lecture "Open Source Drug Discovery as an Innovative Model for Affordable Healthcare for All" has been featured in various print media including Deccan Herald and Times of India
posted Nov 7, 2012, 10:33 PM by Anshu Bhardwaj
[
updated Nov 9, 2012, 1:26 AM
]
A Memorandum of Association (MOU) has been signed by CSIR with Medicines for Malaria Venture for collaboration on Open Source Drug Discovery. This MOU reflects the commitment of OSDD and MMV to fight Malaria, together.
posted Oct 8, 2012, 2:26 AM by Anshu Bhardwaj
[
updated Oct 8, 2012, 2:29 AM
]
In his recent visit to CSIR -National Institute for
Interdisciplinary Science and Technology, Thiruvananthapuram, Prof Samir. K. Brahmachari, DG-CSIR and Chief Mentor OSDD, talked to The Hindu about how molecules synthesized under the OSDD programme are expected to make it to
different stages of clinical trials over the next five year
3Rs for innovating novel antibiotics: sharing resources,risks, and rewards
The article titled , "3Rs for innovating novel antibiotics: sharing resources,risks, and rewards" by Anthony D So et.al discusses how public funding can provide a platform for innovation, citing Open Source Drug Discovery as the example.
